The adverse impact of COVID-19 pandemic on cardiovascular disease prevention and management in England, Scotland and Wales: A population-scale analysis of trends in medication data (2022)

First Author: Dale C

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.12.31.21268587

Publication URI: http://dx.doi.org/10.1101/2021.12.31.21268587

Type: Preprint